OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2021
(2)
2020
(2)
2014
(2)
2023
(1)
2022
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Serology of paracoccidioidomycosis due to Paracoccidioides lutzii.
Not available
S-EPMC4102441
|
biostudies-literature
Cite
Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice.
Not available
S-EPMC9721077
|
biostudies-literature
Cite
Can Molecular Biomarkers Help Reduce the Overtreatment of DCIS?
Not available
S-EPMC10297044
|
biostudies-literature
Cite
A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding.
Not available
S-EPMC3953070
|
biostudies-literature
Cite
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
Not available
S-EPMC8126683
|
biostudies-literature
Cite
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Not available
S-EPMC7762174
|
biostudies-literature
Cite
Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Not available
S-EPMC5467847
|
biostudies-literature
Cite
A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests.
Not available
S-EPMC8099623
|
biostudies-literature
Cite
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
Not available
S-EPMC7598520
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets